Drug Profile
Research programme: non-opioid analgesics - Kineta
Alternative Names: Conopeptide; CSP 4; CSP conopeptide; KCP 400Latest Information Update: 28 Jun 2020
Price :
$50
*
At a glance
- Originator University of Utah
- Developer Kineta; KPI Therapeutics
- Class Conotoxins; Non-opioid analgesics; Peptides
- Mechanism of Action Nicotinic receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Pain